61.02

2.37% -1.62

Bridgebio Pharma Inc (BBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BBIO? Forum Prognose

Schlusskurs vom Vortag:

$62.64

Offen:

$62.74

24-Stunden-Volumen:

1.15M

Relative Volume:

0.45

Marktkapitalisierung:

$11.67B

Einnahmen:

$217.77M

Nettoeinkommen (Verlust:

$-438.86M

KGV:

-25.32

EPS:

-2.41

Netto-Cashflow:

$-456.33M

1W Leistung:

-3.78%

1M Leistung:

+15.69%

6M Leistung:

+58.56%

1J Leistung:

+140.01%

1-Tages-Spanne:

$60.95

$64.19

1-Wochen-Bereich:

$60.99

$69.48

52-Wochen-Spanne:

$21.72

$69.48

Bridgebio Pharma Inc Stock (BBIO) Company Profile

Firmenname

Bridgebio Pharma Inc

Sektor

Healthcare (1139)

Branche

Biotechnology (635)

Telefon

(650) 391-9740

Adresse

3160 PORTER DR., PALO ALTO, CA

Mitarbeiter

730

Twitter

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

BBIO's Discussions on Twitter

Vergleichen Sie BBIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BBIO Bridgebio Pharma Inc	61.03	12.07B	217.77M	-438.86M	-456.33M	-2.41
VRTX Vertex Pharmaceuticals Inc	425.71	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.32	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	432.20	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	821.58	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	184.03	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Bridgebio Pharma Inc Stock (BBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-30	Fortgesetzt	Raymond James	Outperform
2025-07-21	Eingeleitet	Truist	Buy
2025-07-14	Eingeleitet	Jefferies	Buy
2025-07-09	Hochstufung	Oppenheimer	Perform → Outperform
2025-06-17	Eingeleitet	Wolfe Research	Outperform
2025-03-31	Eingeleitet	Redburn Atlantic	Buy
2024-10-16	Eingeleitet	Scotiabank	Sector Outperform
2024-10-03	Eingeleitet	Oppenheimer	Perform
2024-09-04	Eingeleitet	Piper Sandler	Overweight
2024-03-21	Fortgesetzt	Raymond James	Outperform
2024-01-31	Eingeleitet	BMO Capital Markets	Market Perform
2023-12-08	Eingeleitet	Wells Fargo	Overweight
2023-11-07	Eingeleitet	Citigroup	Buy
2023-10-24	Eingeleitet	Cantor Fitzgerald	Overweight
2023-07-18	Herabstufung	Jefferies	Buy → Hold
2023-04-19	Eingeleitet	Evercore ISI	Outperform
2023-02-06	Eingeleitet	Cowen	Outperform
2021-12-27	Bestätigt	Mizuho	Buy
2021-12-27	Bestätigt	SVB Leerink	Outperform
2021-09-10	Hochstufung	BofA Securities	Neutral → Buy
2021-05-21	Eingeleitet	UBS	Buy
2021-03-22	Bestätigt	Goldman	Buy
2021-02-22	Fortgesetzt	JP Morgan	Overweight
2021-02-09	Fortgesetzt	Goldman	Buy
2021-01-11	Bestätigt	H.C. Wainwright	Buy
2020-12-10	Bestätigt	H.C. Wainwright	Buy
2020-06-25	Eingeleitet	BofA/Merrill	Neutral
2020-05-19	Eingeleitet	BTIG Research	Buy
2020-04-13	Eingeleitet	H.C. Wainwright	Buy
2020-02-19	Eingeleitet	Mizuho	Buy
2019-07-26	Eingeleitet	Raymond James	Outperform
2019-07-22	Eingeleitet	BMO Capital Markets	Outperform
2019-07-22	Eingeleitet	Goldman	Buy
2019-07-22	Eingeleitet	JP Morgan	Overweight
2019-07-22	Eingeleitet	Jefferies	Buy
2019-07-22	Eingeleitet	Piper Jaffray	Overweight
2019-07-22	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Bridgebio Pharma Inc Aktie (BBIO) Neueste Nachrichten

09:01 AM

Mizuho Boosts Price Target on BridgeBio Pharma to $91 From $64, Keeps Outperform Rating - MarketScreener

09:01 AM

07:45 AM

BBIO: HC Wainwright & Co. Reiterates Buy Rating with $90 PT | BB - GuruFocus

07:45 AM

07:43 AM

BridgeBio Pharma to Present Ten Digital Posters on Acoramidis at AHA Scientific Sessions 2025 - Quiver Quantitative

07:43 AM

07:37 AM

BBIO: HC Wainwright & Co. Reiterates Buy Rating with $90 PT | BBIO Stock News - GuruFocus

07:37 AM

07:30 AM

BridgeBio (NASDAQ: BBIO) to share 10 AHA 2025 posters on acoramidis ATTRibute-CM data - Stock Titan

07:30 AM

05:09 AM

What moving averages say about BridgeBio Pharma Inc.Weekly Profit Summary & Real-Time Buy Signal Notifications - newser.com

05:09 AM

03:39 AM

New York Life Investment Management LLC Makes New $548,000 Investment in BridgeBio Pharma, Inc. $BBIO - MarketBeat

03:39 AM

02:28 AM

Cantor Fitzgerald Issues Positive Estimate for BBIO Earnings - MarketBeat

02:28 AM

02:25 AM

Using Bollinger Bands to evaluate BridgeBio Pharma Inc.2025 Historical Comparison & Risk Managed Trade Strategies - newser.com

02:25 AM

02:11 AM

What is Leerink Partnrs' Estimate for BBIO FY2025 Earnings? - MarketBeat

02:11 AM

Nov 02, 2025

Can machine learning forecast BridgeBio Pharma Inc. recoveryJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com

Nov 02, 2025

Nisa Investment Advisors LLC Sells 4,667 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Nov 02, 2025

What indicators show strength in BridgeBio Pharma Inc.July 2025 Retail & Verified Momentum Stock Watchlist - newser.com

Nov 02, 2025

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Nov 02, 2025

BridgeBio targets 30%+ market share for Attruby while advancing late-stage pipeline and reporting $120.7M Q3 revenue - MSN

Nov 02, 2025

Nov 01, 2025

Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) Director Sells $13,206,742.22 in Stock - MarketBeat

Nov 01, 2025

Analyzing BridgeBio Pharma Inc. with risk reward ratio charts2025 Market Overview & Community Consensus Stock Picks - newser.com

Nov 01, 2025

Oct 31, 2025